TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 10844388

Group type: EXPERIMENTAL
Intervention: Atrial ejection force (AEF) in patients with SLE and RA
Number of subjects: 37

Group type: COMPARATOR
Intervention: Healthy controls (n = 40) matched for gender and age
Number of subjects: 37
Study: 8945112

Group type: EXPERIMENTAL
Intervention: Smith and Nephew Roylan D-Ring orthosis
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Other 2 commercial wrist extensor orthoses
Number of subjects: 36

Group type: COMPARATOR
Intervention: All 3 commercial orthoses
Number of subjects: 36
Study: 1932838

Group type: EXPERIMENTAL
Intervention: Tamoxifen in post-menopausal patients (ER-negative)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hormonal treatment in post-menopausal patients (ER-positive)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hormonal therapy (oophorectomy + tamoxifen) in pre-menopausal patients
Number of subjects: 0

Group type: COMPARATOR
Intervention: No adjuvant treatment
Number of subjects: 0
Study: 6173514

Group type: EXPERIMENTAL
Intervention: Phentolamine infusion after placebo
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Phentolamine infusion after prazosin (alpha 1-blocker)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Phentolamine infusion after oxprenolol (nonselective beta-blocker)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Phentolamine infusion after prazosin and oxprenolol pretreatment
Number of subjects: 6
Study: 6593309

Group type: EXPERIMENTAL
Intervention: 4'‐epi‐DX
Number of subjects: 8

Group type: COMPARATOR
Intervention: DX
Number of subjects: 8
Study: 29984691

Group type: EXPERIMENTAL
Intervention: Personalised Oral Hygiene Advice (OHA)
Number of subjects: 1877

Group type: EXPERIMENTAL
Intervention: 6-monthly Periodontal Instrumentation (PI)
Number of subjects: 1877

Group type: EXPERIMENTAL
Intervention: 12-monthly PI
Number of subjects: 1877

Group type: EXPERIMENTAL
Intervention: 6-monthly PI
Number of subjects: 1877

Group type: EXPERIMENTAL
Intervention: Personalised OHA with 6-monthly PI
Number of subjects: 1877

Group type: COMPARATOR
Intervention: No PI with Personalised OHA
Number of subjects: 1877
Study: 26679763

Group type: EXPERIMENTAL
Intervention: n-3 PUFA (2.2 g/day)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Olive oil placebo
Number of subjects: 71
Study: 24965494

Group type: EXPERIMENTAL
Intervention: Osteopathic manual treatment (OMT)
Number of subjects: 186

Group type: COMPARATOR
Intervention: Sham OMT
Number of subjects: 186
Study: 23077137

Group type: EXPERIMENTAL
Intervention: Sitagliptin 100-mg administered on Day 5 of a 7 day course of simvastatin 80-mg once daily
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sitagliptin 100-mg alone
Number of subjects: 10
Study: 20889472

Group type: EXPERIMENTAL
Intervention: Participants who reported binge eating prior to or during treatment
Number of subjects: 186

Group type: COMPARATOR
Intervention: Participants without binge eating
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Group that experienced an emergence of binge eating
Number of subjects: 186
Study: 18565950

Group type: EXPERIMENTAL
Intervention: Prenatal cigarette smoke exposure
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control (nonsmoking mothers)
Number of subjects: 22
Study: 16496813

Group type: EXPERIMENTAL
Intervention: Experimental protocol (n=93)
Number of subjects: 189

Group type: COMPARATOR
Intervention: Standard practice (n=96)
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 189
Study: 12536245

Group type: EXPERIMENTAL
Intervention: Indirect radionuclide cystography (IRNC) using technetium‐99m diethylene triamine penta‐acetate (DTPA) with a dosage of 37 MBq/10 kg body weight.
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: IRNC
Number of subjects: 74
Study: 10532438

Group type: EXPERIMENTAL
Intervention: Latanoprost, 0.005%, 1 drop per day in each eye
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo, 1 drop per day in each eye
Number of subjects: 24
Study: 8896777

Group type: EXPERIMENTAL
Intervention: Bright white light (2500 lx) for 2 hours daily for 1 week
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Dim red light (50 lx) for 2 hours daily for 1 week
Number of subjects: 34

Group type: COMPARATOR
Intervention: Bright and dim light treatment
Number of subjects: 34

Group type: COMPARATOR
Intervention: Healthy controls receiving bright or dim light
Number of subjects: 34
Study: 1676467

Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation (60,000 retinol equivalents every 4 months)
Number of subjects: 28630

Group type: COMPARATOR
Intervention: Placebo (300 retinol equivalents)
Number of subjects: 28630
Study: 6630409

Group type: EXPERIMENTAL
Intervention: Standardized mixed meal
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: High protein meals
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: High fat meals
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: L-tyrosine and L-tryptophan
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Choline
Number of subjects: 7

Group type: COMPARATOR
Intervention: Prior receptor blockade with naloxone and atropine
Number of subjects: 7
Study: 30366712

Group type: EXPERIMENTAL
Intervention: Implementation intentions (II) training
Number of subjects: 42

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 42
Study: 29490895

Group type: EXPERIMENTAL
Intervention: Digital interventions for reducing hazardous and harmful alcohol consumption
Number of subjects: 41
Study: 26660041

Group type: EXPERIMENTAL
Intervention: 30% ethanol/4% sodium citrate
Number of subjects: 40

Group type: COMPARATOR
Intervention: heparin 1000 units/mL
Number of subjects: 40
Study: 24933232

Group type: EXPERIMENTAL
Intervention: Bariatric surgery (gastric bypass)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Healthy blood donors (control group)
Number of subjects: 150
Study: 21816443

Group type: EXPERIMENTAL
Intervention: High-fat diet (37% energy from fat and 50% from carbohydrates)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Low-fat diet (25% energy from fat and 62% from carbohydrates)
Number of subjects: 12
Study: 20837894

Group type: EXPERIMENTAL
Intervention: ICD therapy
Number of subjects: 1232

Group type: COMPARATOR
Intervention: Non-ICD medical therapy
Number of subjects: 1232
Study: 17663103

Group type: EXPERIMENTAL
Intervention: Needle retention at Baihui (GV 20) for 8 h and electroacupuncture at local points
Number of subjects: 120

Group type: COMPARATOR
Intervention: Needle retention at Baihui (GV 20) for 30 min and electroacupuncture at local points
Number of subjects: 120
Study: 16105001

Group type: EXPERIMENTAL
Intervention: Accelerometer sensor device
Number of subjects: 1245

Group type: EXPERIMENTAL
Intervention: Piezoelectric sensor
Number of subjects: 1245

Group type: EXPERIMENTAL
Intervention: Blended sensor
Number of subjects: 1245
Study: 12810740

Group type: EXPERIMENTAL
Intervention: Hip protectors
Number of subjects: 600

Group type: COMPARATOR
Intervention: Control group (no hip protectors)
Number of subjects: 600
Study: 10418644

Group type: EXPERIMENTAL
Intervention: Propacetamol 30 mg/kg i.v. (repeated after 6 hours)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Tenoxicam 0.5 mg/kg i.v. (max. 40 mg)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Combination of propacetamol and tenoxicam
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 7737552

Group type: EXPERIMENTAL
Intervention: 10 mg omeprazole once daily
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: 20 mg omeprazole once daily
Number of subjects: 193

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 193
Study: 1975448

Group type: EXPERIMENTAL
Intervention: Remoxipride
Number of subjects: 71

Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 71
Study: 6117301

Group type: EXPERIMENTAL
Intervention: Diazepam in oil (Diazemuls)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Midazolam (Dormicum)
Number of subjects: 100
Study: 30968815

Group type: EXPERIMENTAL
Intervention: Increased water intake among pilgrims over 40 years of age (89.5%) compared to those under 40 years (76.5%)
Number of subjects: 412

Group type: EXPERIMENTAL
Intervention: Use of cotton clothes among those aware of Mecca's weather (51.8%) compared to those unaware (36.0%)
Number of subjects: 412

Group type: EXPERIMENTAL
Intervention: Going out at noon time among educated pilgrims (7.3%) compared to those with lower education (15.4%)
Number of subjects: 412
Study: 28039245

Group type: COMPARATOR
Intervention: ondansetron 4 mg i.v.
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: chewing gum
Number of subjects: 94
Study: 25967705

Group type: EXPERIMENTAL
Intervention: Laparoscopy
Number of subjects: 100

Group type: COMPARATOR
Intervention: Traditional surgery (Control)
Number of subjects: 100
Study: 23622912

Group type: EXPERIMENTAL
Intervention: Normal eGFR (≥90 mL/min)
Number of subjects: 942

Group type: EXPERIMENTAL
Intervention: Mild CKD (60-89 mL/min)
Number of subjects: 942

Group type: EXPERIMENTAL
Intervention: Moderate CKD (30-59 mL/min)
Number of subjects: 942

Group type: EXPERIMENTAL
Intervention: Severe CKD (<30 mL/min)
Number of subjects: 942

Group type: EXPERIMENTAL
Intervention: Chronic Hemodialysis (HD)
Number of subjects: 942
Study: 21839455

Group type: EXPERIMENTAL
Intervention: LFHCC n‐3 diet (low-fat high-carbohydrate diet supplemented with 1.24g/day of long‐chain n‐3 polyunsaturated fatty acids)
Number of subjects: 337

Group type: COMPARATOR
Intervention: HSFA diet (high saturated fat diet)
Number of subjects: 337

Group type: COMPARATOR
Intervention: HMUFA diet (high monounsaturated fat diet)
Number of subjects: 337

Group type: COMPARATOR
Intervention: LFHCC diet (low-fat high-carbohydrate diet with placebo)
Number of subjects: 337
Study: 19339808

Group type: EXPERIMENTAL
Intervention: Pollen group (received grass pollen, grass and olive pollen, or hazel, alder and birch pollen according to a 3-week titration cluster)
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: HDM group (received HDM extract according to a 2-week titration cluster)
Number of subjects: 157
Study: 17038230

Group type: EXPERIMENTAL
Intervention: Culture-based antibiotics
Number of subjects: 60

Group type: COMPARATOR
Intervention: Empiric amoxicillin-clavulanate (40 mg/kg/day)
Number of subjects: 60
Study: 15053895

Group type: EXPERIMENTAL
Intervention: Immunologic therapies (specifics not provided)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral insulin (single dose)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: DPT-1 parenteral trials (insulin administration)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Newer assays (tetramers, enzyme-linked immunospot assays)
Number of subjects: 0
Study: 10757146

Group type: EXPERIMENTAL
Intervention: Small dose instruction
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Large dose instruction
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Beer
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Mixed drinks
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Straight liquor
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Wine
Number of subjects: 130
Study: 9089564

Group type: EXPERIMENTAL
Intervention: 2 mg E2V for 11 days, followed by 2 mg E2V + 10 mg MPA for 10 days and placebo for 7 days
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: 2 mg E2V for 70 days, 2 mg E2V + 20 mg MPA for 14 days, and placebo for 7 days
Number of subjects: 78

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study: 8385230

Group type: EXPERIMENTAL
Intervention: Standard methadone services (SMS) - same dose of methadone plus counseling
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Enhanced methadone services (EMS) - same dose of methadone plus counseling and on-site medical/psychiatric, employment, and family therapy
Number of subjects: 92

Group type: COMPARATOR
Intervention: Minimum methadone services (MMS) - methadone alone (a minimum of 60 mg/d) with no other services
Number of subjects: 92
Study: 3544605

Group type: EXPERIMENTAL
Intervention: Low-molecular weight heparin-dihydroergotamine once a day
Number of subjects: 200

Group type: COMPARATOR
Intervention: Heparin-dihydroergotamine twice a day
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 200
Study: 29644504

Group type: COMPARATOR
Intervention: Never smokers
Number of subjects: 1242

Group type: EXPERIMENTAL
Intervention: Ever smokers
Number of subjects: 1242
Study: 27403059

Group type: EXPERIMENTAL
Intervention: Carie-care (chemomechanical caries removal) in clinical setting
Number of subjects: 80

Group type: COMPARATOR
Intervention: Smart Burs (mechanical caries removal) in clinical setting
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Carie-care (chemomechanical caries removal) in community setting
Number of subjects: 80

Group type: COMPARATOR
Intervention: Atraumatic restorative technique (ART) in community setting
Number of subjects: 80
Study: 25385173

Group type: EXPERIMENTAL
Intervention: telmisartan and atorvastatin (ARB)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: enalapril and atorvastatin (ACEI)
Number of subjects: 41

Group type: COMPARATOR
Intervention: CAD group
Number of subjects: 41

Group type: COMPARATOR
Intervention: non-CAD group
Number of subjects: 41
Study: 23523162

Group type: EXPERIMENTAL
Intervention: Genotype + Phenotype model
Number of subjects: 2415

Group type: COMPARATOR
Intervention: Phenotype model
Number of subjects: 2415

Group type: EXPERIMENTAL
Intervention: Smoking status and ARMS2 genotype
Number of subjects: 2415
Study: 21701080

Group type: EXPERIMENTAL
Intervention: Transoral EGD
Number of subjects: 25

Group type: COMPARATOR
Intervention: Transnasal EGD
Number of subjects: 25
Study: 19623684

Group type: COMPARATOR
Intervention: Dietary measures and treadmill training at 60% HRmax (G2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dietary measures, treadmill training at 60% HRmax, and strength training (G3)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (G1)
Number of subjects: 0
Study: 16682738

Group type: EXPERIMENTAL
Intervention: Combination of cisplatin and fluorouracil (reference arm in Western trials)
Number of subjects: 2600

Group type: COMPARATOR
Intervention: Single-agent fluorouracil or S-1 (used in Japanese trials)
Number of subjects: 2600

Group type: EXPERIMENTAL
Intervention: Triplet regimens (used in Western studies)
Number of subjects: 2600

Group type: EXPERIMENTAL
Intervention: Newer regimens (upcoming in Europe and Asia)
Number of subjects: 2600
Study: 15450636

Group type: EXPERIMENTAL
Intervention: Partner-assisted (PA) intervention
Number of subjects: 583

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 583

Group type: EXPERIMENTAL
Intervention: Woman-only (WO)
Number of subjects: 583
Study: 11171710

Group type: EXPERIMENTAL
Intervention: Hospital-based home-care program (HCP)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Conventional medical care (Control)
Number of subjects: 122
Study: 9312453

Group type: EXPERIMENTAL
Intervention: Halothane, nitrous oxide, and ondansetron (Group O)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Propofol and nitrous oxide (Group P)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 300

Group type: COMPARATOR
Intervention: Propofol-based anaesthesia
Number of subjects: 300
Study: 7584301

Group type: EXPERIMENTAL
Intervention: Experienced infants (10-month-olds)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Children with experiences at both 10 months and 14 months
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Children with a single 14-month experience
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Combined experience groups (from Studies 1 and 2)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Experienced children
Number of subjects: 51
Study: 2572911

Group type: EXPERIMENTAL
Intervention: Endosonography
Number of subjects: 52

Group type: COMPARATOR
Intervention: Ultrasonography
Number of subjects: 52

Group type: COMPARATOR
Intervention: CT
Number of subjects: 52
Study: 950374

Group type: EXPERIMENTAL
Intervention: Insulin (0.1 IU/kg BW) administered at various times (0400 h, 0800 h, 1200 h, 1600 h, 2000 h, 2400 h)
Number of subjects: 4
Study: 31589074

Group type: EXPERIMENTAL
Intervention: Intermittent Hypoxia/Hyperoxia Training (IHHT)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Intermittent Hypoxia/Normoxia Training (IHT)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Sham control (placebo)
Number of subjects: 55
Study: 28343696

Group type: EXPERIMENTAL
Intervention: In situ hypothermic perfusion with retrograde outflow
Number of subjects: 18

Group type: COMPARATOR
Intervention: Intermittent vascular inflow occlusion
Number of subjects: 18
Study: 26121460

Group type: EXPERIMENTAL
Intervention: Basal-bolus regimen with glargine once daily and glulisine before meals (n = 66)
Number of subjects: 134

Group type: COMPARATOR
Intervention: NPH twice daily and regular insulin before meals (n = 68)
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Basal-bolus regimen with glargine/glulisine
Number of subjects: 134

Group type: COMPARATOR
Intervention: NPH/regular regimen
Number of subjects: 134
Study: 24739235

Group type: EXPERIMENTAL
Intervention: Intervention group (n = 40) with access to a nurse-managed telephone support line and colorectal cancer screening website
Number of subjects: 2395

Group type: COMPARATOR
Intervention: Control group (n = 39) with standard clinical screening practice
Number of subjects: 2395

Group type: EXPERIMENTAL
Intervention: Patients whose physician promoted the FOBT
Number of subjects: 2395

Group type: EXPERIMENTAL
Intervention: Patients who reported having done an FOBT in the past
Number of subjects: 2395

Group type: EXPERIMENTAL
Intervention: Patients aged 50-59 years
Number of subjects: 2395

Group type: EXPERIMENTAL
Intervention: Patients completing the test
Number of subjects: 2395
Study: 22180596

Group type: EXPERIMENTAL
Intervention: Neighborhood perceptions (neighborhood problems and neighborhood vigilance)
Number of subjects: 384
Study: 20683380

Group type: EXPERIMENTAL
Intervention: ranibizumab (0.3 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ranibizumab (0.5 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (photodynamic therapy)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (sham)
Number of subjects: 0
Study: 18618933

Group type: EXPERIMENTAL
Intervention: ACOG recommendations
Number of subjects: 90

Group type: COMPARATOR
Intervention: Randomized clinical trials (RCTs)
Number of subjects: 90
Study: 16191910

Group type: EXPERIMENTAL
Intervention: Oral health program including parent education, toothbrushing instruction, and fluoride tablets (0.25 mg/day)
Number of subjects: 804

Group type: EXPERIMENTAL
Intervention: Oral health program
Number of subjects: 804
Study: 14639093

Group type: EXPERIMENTAL
Intervention: Irbesartan
Number of subjects: 115
Study: 10655292

Group type: EXPERIMENTAL
Intervention: Medi-Jector administration of ganirelix (2 mg s.c. once daily for 7 days)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Conventional needle injection of ganirelix (2 mg s.c. once daily for 7 days)
Number of subjects: 16
Study: 9547443

Group type: EXPERIMENTAL
Intervention: Imidapril
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 8290683

Group type: EXPERIMENTAL
Intervention: Haloperidol (≤ 6 mg)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Phenelzine (≤ 90 mg)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 2961039

Group type: EXPERIMENTAL
Intervention: Combination analgesic/muscle relaxant
Number of subjects: 0

Group type: COMPARATOR
Intervention: Components of the combination therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30588067

Group type: EXPERIMENTAL
Intervention: Manual Pressure Release (MPR)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Muscle Energy Technique (MET)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control condition (postural advice and at-home neck exercises)
Number of subjects: 45
Study: 27742577

Group type: EXPERIMENTAL
Intervention: Controlled-release oral morphine
Number of subjects: 185

Group type: COMPARATOR
Intervention: Oxycodone
Number of subjects: 185
Study: 24452727

Group type: EXPERIMENTAL
Intervention: Clopidogrel
Number of subjects: 3491
Study: 22905819

Group type: EXPERIMENTAL
Intervention: Attending to the action
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Attending to the object
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Congruent action-object clips
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Congruency in different tasks
Number of subjects: 0
Study: 21122603

Group type: EXPERIMENTAL
Intervention: First-trimester ultrasound screening for Down syndrome (DS)
Number of subjects: 2026

Group type: COMPARATOR
Intervention: Routine ultrasound examination in the second trimester
Number of subjects: 2026
Study: 18775429

Group type: EXPERIMENTAL
Intervention: Anti-Hp therapy plus iron (amoxicillin, clarithromycin, and omeprazole + 90-day oral ferrous sulfate)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Iron alone (90-day oral iron)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Anti-Hp therapy alone (2-week anti-Hp therapy)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Anti-Hp therapy plus iron
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Iron alone
Number of subjects: 200

Group type: COMPARATOR
Intervention: Anti-Hp therapy alone
Number of subjects: 200
Study: 16394323

Group type: EXPERIMENTAL
Intervention: Curcumin (500 mg) with piperine (5 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 12891198

Group type: EXPERIMENTAL
Intervention: Amlodipine (10 mg/day)
Number of subjects: 181

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 181
Study: 10552188

Group type: EXPERIMENTAL
Intervention: tedisamil 100 mg b.i.d.
Number of subjects: 48

Group type: COMPARATOR
Intervention: atenolol 50 mg b.i.d.
Number of subjects: 48
Study: 8911832

Group type: EXPERIMENTAL
Intervention: NaHCO3 (0.3 g.kg‐1 body mass)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo (CaCO3)
Number of subjects: 7
Study: 8388090

Group type: EXPERIMENTAL
Intervention: IV cyclophosphamide/ACTH with outpatient IV cyclophosphamide boosters (700 mg/m2 every other month for 2 years)
Number of subjects: 256

Group type: COMPARATOR
Intervention: IV cyclophosphamide/ACTH without outpatient IV cyclophosphamide boosters
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: IV cyclophosphamide/ACTH with outpatient IV cyclophosphamide boosters
Number of subjects: 256